Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats

European Journal of Pharmacology

Volumn 365, Issue 2-3, 1999, Pages 241-251

  Kwan, Yiu Wa ^a   To, Kin Wah ^a   Lau, Wai Man ^a   Tsang, Shiu Hei ^a  

^a NONE

Author keywords

ATP sensitive K+ channel; Pulmonary artery; Spontaneously hypertensive rat (SHR); Thoracic aorta

Indexed keywords

2 (1,3 DIOXOLAN 2 YL) 2 METHYL 6 NITRO 4 (2 OXO 1 PYRROLIDINYL) 2H 1 BENZOPYRAN; 2 [2'' (1'',3'' DIOXOLONE) 2 METHYL 4 (2' OXO 1' PYRROLIDINYL)] 6 NITRO 2H 1 BENZOPYRAN; 6 ANILINO 5,8 QUINOLINEQUINONE; ADENOSINE TRIPHOSPHATE; APRIKALIM; N(G) NITROARGININE METHYL ESTER; NICORANDIL; NITROPRUSSIDE SODIUM; PINACIDIL; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; VASODILATATION;

ADENOSINE TRIPHOSPHATE; AMINOQUINOLINES; ANIMALS; AORTA, THORACIC; APAMIN; BENZOPYRANS; CHARYBDOTOXIN; CROMAKALIM; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; HYPERTENSION; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NICORANDIL; NITROPRUSSIDE; NOREPINEPHRINE; PICOLINES; PINACIDIL; POTASSIUM; POTASSIUM CHANNELS; PULMONARY ARTERY; PYRANS; PYRROLIDINONES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VASODILATOR AGENTS;

EID: 0032939333     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00768-7     Document Type: Article

References (53)

1. Aharinejad S., Schraufnagel D.E., Böck P., Mackay C.A., Larson E.K., Miksovsky A., Marks S.C. Jr. Spontaneously hypertensive rats develop pulmonary hypertension and hypertrophy of pulmonary venous sphincters. Am. J. Pathol. 148:1996;281-290.
2. Altura B.M. Neurohypophyseal hormones and analogues; rat pressor potency versus contractile potency on rat arterioles and arteries. Proc. Soc. Exp. Biol. Med. 146:1974;1054-1060.
3. + channels in heart cells by pinacidil: dependence on ATP. Am. J. Physiol. 257:1989;H2092-H2096.
4. Asano M., Masuzawa-Ito K., Matsuda T. Vasodilating actions of cromakalim in resting and contracting states of carotid arteries from spontaneously hypertensive rats. Eur. J. Pharmacol. 263:1994;121-131.
5. Aschroft F.M. Adenosine 5′-triphosphate-sensitive potassium channels. Annu. Rev. Neurosci. 11:1990;97-118.
6. Belles B., Hescheler J., Trube G. Changes of membrane currents in cardiac cells induced by long whole-cell recordings and tolbutamide. Pflug. Arch. 409:1987;582-588.
7. Camerini F., Alberti E., Klugmann S., Salvi A. Primary pulmonary hypertension: effects of nifedipine. Br. Heart J. 44:1980;352-356.
8. + channel pulmonary vasodilation in fetal lambs: role of endothelium-derived nitric oxide. J. Appl. Physiol. 73:1992;188-194.
9. Clineschmidt B.V., Geller R.G., Govier W.C., Sjoerdsma A. Reactivity to norepinephrine and nature of the alpha adrenergic receptor in vascular smooth muscle of a genetically hypertensive rat. Eur. J. Pharmacol. 10:1970;45-50.
10. Cook N.S. The pharmacology of potassium channel and their therapeutic potential. Trends Pharmacol. Sci. 9:1988;21-28.
11. Crawley D.E., Zhao L., Giembycz M.A., Liu S., Barnes P.J., Winter R.J.D., Evans T.W. Chronic hypoxia impairs soluble guanylate cyclase-mediated pulmonary artery relaxation in the rat. Am. J. Physiol. 263:1992;L325-L332.
12. Daoud F.S., Reeves J.T., Kelley D.B. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am. J. Cardiol. 42:1978;817-822.
13. Di Somma S., Liguori V., Petitto M., Carotenuto A., Bokor D., De Divitiis O., De Divitiis M. A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris. Cardiovasc. Drugs Ther. 7:1993;119-123.
14. + channel openers. Trends Pharmacol. Sci. 11:1990;417-422.
15. + channels in rat ventricular myocytes are blocked and inactivated by internal divalent cations. Pflug. Arch. 410:1987;313-320.
16. ATP channels. Interactions with nucleotides and protons. J. Gen. Physiol. 107:1996;489-502.
17. + channel from rabbit aorta: modulation by cromakalim. Eur. J. Pharmacol. 167:1989;201-210.
18. Greenwood I.A., Weston A.H. Effects of rubidium on responses to potassium channel openers in rat isolated aorta. Br. J. Pharmacol. 109:1993;925-932.
19. + channel current in atrial myocytes of guinea pig heart. Jpn. J. Pharmacol. 54:1990;473-477.
20. + current by nicorandil (2-nicotinamidoethyl mitrate) in isolated ventricular myocytes. J. Pharmacol. Exp. Ther. 250:1989;278-285.
21. Horie M., Irisawa H., Noma A. Voltage-dependent magnesium block of adenosine-triphosphate-sensitive potassium channels in guinea-pig ventricular cells. J. Physiol. 387:1987;251-272.
22. + channels in rat portal vein J. Pharmacol. Exp. Ther. 253:1990;771-777.
23. Hüsken B.C.P., Hendriks M.G.C., Pfaffendorf M., Van Zwieten P.A. Effects of aging and hypertension on the reactivity of isolated conduit and resistance vessels. Microvasc. Res. 48:1994;303-315.
24. Kashiwabara T., Nakajima T., Kasai H., Nakajima S., Izawa T., Ogawa N. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta. Arch. Int. Pharmacodyn. Ther. 327:1994;175-183.
25. Kukovetz W.R., Holzmann S., Braida C., Pöch G. Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization. J. Cardiovasc. Pharmacol. 17:1991;627-633.
26. + channel. J. Pharmacol. Exp. Ther. 275:1995;807-812.
27. Lograno M.D., Daniele E., Galli C. Changes of vascular smooth muscle reactivity in hypertensive rats. Pharmacol. Res. 21:1989;719-728.
28. Longman S.D., Hamilton T.C. Potassium channel activator drugs: mechanism of action, pharmacological properties, and therapeutic potential. Med. Res. Rev. 12:1992;73-148.
29. + channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen. J. Pharmacol. Exp. Ther. 268:1994;1411-1418.
30. + channels in cardiac muscle. Nature. 305:1983;147-148.
31. Noma A., Shibasaki T. Membrane through adenosine-triphosphate regulated potassium channels in guinea-pig ventricular cells. J. Physiol. 363:1985;463-480.
32. 2α or endothelin. Br. J. Pharmacol. 102:1991;311-316.
33. + channels in mesenteric artery cells from spontaneously hypertensive rats. Hypertension. 27:1996;1234-1239.
34. Palevsky H.I., Fishman A.P. Vasodilator therapy for primary pulmonary hypertension. Annu. Rev. Med. 36:1985;563-578.
35. Quast U. Potassium channel openers: pharmacological and clinic aspects. Fundam. Clin. Pharmacol. 6:1992;279-293.
36. Rubin L.J., Peter R.H. Oral hydralazine therapy for primary pulmonary hypertension. N. Eng. J. Med. 302:1980;69073.
37. Ruskin J.N., Hutter A.M. Primary pulmonary hypertension treated with oral phentolamine. Ann. Intern. Med. 90:1979;772-774.
38. + current in cardiac muscle. Proc. Natl. Acad. Sci. USA. 85:1988;8360-8364.
39. Satake N., Zhou Q., Morikawa M., Inoue M., Shibata S. Potentiating effect of nicorandil, an antianginal agent, on relaxation induced by isoproterenol in isolated rat aorta: involvement of cyclic GMP inhibitable cyclic AMP phosphodiesterase. J. Cardiovasc. Pharmacol. 25:1995;489-494.
40. Savineau J.P., Marthan R. Effect of cromakalim on KCl-, noradrenaline- and angiotensin II-induced contractions in the rat pulmonary artery. Pulm. Pharmacol. 6:1993;41-48.
41. + channels. A comparison with pinacidil and lemakalim. Circ. Res. 69:1991;1152-1158.
42. Shirasaki Y., Su C., Lee T.J.F., Kolm P., Cline W.H. Jr., Nickols G.A. Endothelial modulation of vascular relaxation to nitrovasodilators in aging and hypertension. J. Pharmacol. Exp. Ther. 239:1986;861-866.
43. Smith J.M., Wahler G.M. ATP-sensitive potassium channels are altered in ventricular myocytes from diabetic rats. Mol. Cell. Biochem. 158:1996;43-51.
44. Spector S., Fleisch J.H., Maling H.M., Brodie B.B. Vascular smooth muscle reactivity in normotensive and hypertensive rats. Science. 166:1969;1300-1301.
45. + channels in arterial smooth muscle. Science. 245:1989;177-180.
46. + channels. Biochem. Biophys. Res. Commun. 181:1991;172-178.
47. ATP channels, induced by aprikalim and nucleotides, in excised membrane patches from cardiac myocytes. Br. J. Pharmacol. 115:1995;117-127.
48. Tuttle J.B., Spitsbergen J.M., Stewart J.S., McCarty R.M., Steers W.D. Altered signalling in vascular smooth muscle from spontaneously hypertensive rats may link medial hypertrophy, vessel hyperinnervation and elevated nerve growth factor. Clin. Exp. Pharmacol. Physiol. 1:1995;S117-S119.
49. Wanstall J.C. In vitro hypoxia attenuates vasorelaxation by potassium channel opening drugs and nitroprusside in isolated pulmonary arteries from rats. J. Pharmacol. Exp. Ther. 271:1994;845-851.
50. Wanstall J.C., O'Donnell S.R. Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats. Br. J. Pharmacol. 105:1992;152-158.
51. Wanstall J.C., Thompson J.S., Morice A.H. Effects of atrial natriuretic peptide and nitroprusside on isolated pulmonary resistance and conduit arteries from rats with pulmonary hypertension. Br. J. Pharmacol. 110:1993;1363-1368.
52. Wanstall J.C., Kay C.S., O'Donnell S.R. Pinacidil-induced relaxation in pulmonary arteries isolated from pulmonary hypertensive and normotensive rats and pre-contracted with different spasmogens. Pulm. Pharmacol. 7:1994;401-408.
53. Zhou Q., Satake N., Shibata S. The inhibitory mechanisms of nicorandil in isolated rat urinary bladder and femoral artery. Eur. J. Pharmacol. 273:1995;153-159.